Industry: Medical Devices & Consumables
Published Date: 2026-01-05
Pages: 156 Pages
Report ld: 5519103
Request Sample
Customized Report
Lab Automation in Proteomics Market Size(US$)

CAGR 2026-2032
6.4%
Market Size,2032
USD 4,513
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Lab Automation in Proteomics market was valued at US$ 2950 million in 2025 and is anticipated to reach US$ 4513 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Lab Automation in Proteomics competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
The global key players of lab automation in proteomics include Thermo Fisher, Beckman Coulter (Danaher), Agilent Technologies, PerkinElmer, Roche, Siemens Healthineers, BD, and Waters, etc. The global top 8 players hold a share over 60%. North America is the largest producer, has a share about 50%, followed by Europe, with a share about 30%. In terms of product type, analytical automation segment occupies for over 60%, while in terms of end users, biotechnology and pharmaceutical companies are the largest segment, with a share over 40%.
This report delivers a comprehensive overview of the global Lab Automation in Proteomics market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Lab Automation in Proteomics. The Lab Automation in Proteomics market size, estimates, and forecasts are provided in terms of sales volume (Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Lab Automation in Proteomics market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Lab Automation in Proteomics manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Lab Automation in Proteomics manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Lab Automation in Proteomics sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Lab Automation in Proteomics Market Overview
1.1 Product Definition
1.2 Lab Automation in Proteomics by Type
1.2.1 Global Lab Automation in Proteomics Market Value by Type: 2025 vs 2032
1.2.2 Pre-analytical Automation
1.2.3 Analytical Automation
1.2.4 Post-analytical Automation
1.2.5 Total Lab Automation
1.3 Lab Automation in Proteomics by Application
1.3.1 Global Lab Automation in Proteomics Market Value by Application: 2025 vs 2032
1.3.2 Biotechnology and Pharmaceutical Companies
1.3.3 Hospitals and Diagnostic Laboratories
1.3.4 Research and Academic Institutes
1.3.5 Others
1.4 Global Lab Automation in Proteomics Market Size Estimates and Forecasts
1.4.1 Global Lab Automation in Proteomics Revenue 2021–2032
1.4.2 Global Lab Automation in Proteomics Sales 2021–2032
1.4.3 Global Lab Automation in Proteomics Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Lab Automation in Proteomics Market Competition by Manufacturers
2.1 Global Lab Automation in Proteomics Sales Market Share by Manufacturers (2021–2026)
2.2 Global Lab Automation in Proteomics Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Lab Automation in Proteomics Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Lab Automation in Proteomics, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Lab Automation in Proteomics, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Lab Automation in Proteomics, Product Types and Applications
2.7 Global Key Manufacturers of Lab Automation in Proteomics, Date of Entry into the Industry
2.8 Global Lab Automation in Proteomics Market Competitive Situation and Trends
2.8.1 Global Lab Automation in Proteomics Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Lab Automation in Proteomics Players Market Share by Revenue
2.8.3 Global Lab Automation in Proteomics Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lab Automation in Proteomics Market Scenario by Region
3.1 Global Lab Automation in Proteomics Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Lab Automation in Proteomics Sales by Region: 2021–2032
3.2.1 Global Lab Automation in Proteomics Sales by Region: 2021–2026
3.2.2 Global Lab Automation in Proteomics Sales by Region: 2027–2032
3.3 Global Lab Automation in Proteomics Revenue by Region: 2021–2032
3.3.1 Global Lab Automation in Proteomics Revenue by Region: 2021–2026
3.3.2 Global Lab Automation in Proteomics Revenue by Region: 2027–2032
3.4 North America Lab Automation in Proteomics Market Facts & Figures by Country
3.4.1 North America Lab Automation in Proteomics Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Lab Automation in Proteomics Sales by Country (2021–2032)
3.4.3 North America Lab Automation in Proteomics Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lab Automation in Proteomics Market Facts & Figures by Country
3.5.1 Europe Lab Automation in Proteomics Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Lab Automation in Proteomics Sales by Country (2021–2032)
3.5.3 Europe Lab Automation in Proteomics Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lab Automation in Proteomics Market Facts & Figures by Region
3.6.1 Asia Pacific Lab Automation in Proteomics Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Lab Automation in Proteomics Sales by Region (2021–2032)
3.6.3 Asia Pacific Lab Automation in Proteomics Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Lab Automation in Proteomics Market Facts & Figures by Country
3.7.1 Latin America Lab Automation in Proteomics Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Lab Automation in Proteomics Sales by Country (2021–2032)
3.7.3 Latin America Lab Automation in Proteomics Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lab Automation in Proteomics Market Facts & Figures by Country
3.8.1 Middle East and Africa Lab Automation in Proteomics Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Lab Automation in Proteomics Sales by Country (2021–2032)
3.8.3 Middle East and Africa Lab Automation in Proteomics Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lab Automation in Proteomics Sales by Type (2021–2032)
4.1.1 Global Lab Automation in Proteomics Sales by Type (2021–2026)
4.1.2 Global Lab Automation in Proteomics Sales by Type (2027–2032)
4.1.3 Global Lab Automation in Proteomics Sales Market Share by Type (2021–2032)
4.2 Global Lab Automation in Proteomics Revenue by Type (2021–2032)
4.2.1 Global Lab Automation in Proteomics Revenue by Type (2021–2026)
4.2.2 Global Lab Automation in Proteomics Revenue by Type (2027–2032)
4.2.3 Global Lab Automation in Proteomics Revenue Market Share by Type (2021–2032)
4.3 Global Lab Automation in Proteomics Price by Type (2021–2032)
5 Segment by Application
5.1 Global Lab Automation in Proteomics Sales by Application (2021–2032)
5.1.1 Global Lab Automation in Proteomics Sales by Application (2021–2026)
5.1.2 Global Lab Automation in Proteomics Sales by Application (2027–2032)
5.1.3 Global Lab Automation in Proteomics Sales Market Share by Application (2021–2032)
5.2 Global Lab Automation in Proteomics Revenue by Application (2021–2032)
5.2.1 Global Lab Automation in Proteomics Revenue by Application (2021–2026)
5.2.2 Global Lab Automation in Proteomics Revenue by Application (2027–2032)
5.2.3 Global Lab Automation in Proteomics Revenue Market Share by Application (2021–2032)
5.3 Global Lab Automation in Proteomics Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher
6.1.1 Thermo Fisher Company Information
6.1.2 Thermo Fisher Description and Business Overview
6.1.3 Thermo Fisher Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Lab Automation in Proteomics Product Portfolio
6.1.5 Thermo Fisher Recent Developments/Updates
6.2 Beckman Coulter (Danaher)
6.2.1 Beckman Coulter (Danaher) Company Information
6.2.2 Beckman Coulter (Danaher) Description and Business Overview
6.2.3 Beckman Coulter (Danaher) Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Beckman Coulter (Danaher) Lab Automation in Proteomics Product Portfolio
6.2.5 Beckman Coulter (Danaher) Recent Developments/Updates
6.3 Agilent Technologies
6.3.1 Agilent Technologies Company Information
6.3.2 Agilent Technologies Description and Business Overview
6.3.3 Agilent Technologies Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Agilent Technologies Lab Automation in Proteomics Product Portfolio
6.3.5 Agilent Technologies Recent Developments/Updates
6.4 PerkinElmer
6.4.1 PerkinElmer Company Information
6.4.2 PerkinElmer Description and Business Overview
6.4.3 PerkinElmer Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 PerkinElmer Lab Automation in Proteomics Product Portfolio
6.4.5 PerkinElmer Recent Developments/Updates
6.5 Roche
6.5.1 Roche Company Information
6.5.2 Roche Description and Business Overview
6.5.3 Roche Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Roche Lab Automation in Proteomics Product Portfolio
6.5.5 Roche Recent Developments/Updates
6.6 Siemens Healthineers
6.6.1 Siemens Healthineers Company Information
6.6.2 Siemens Healthineers Description and Business Overview
6.6.3 Siemens Healthineers Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Siemens Healthineers Lab Automation in Proteomics Product Portfolio
6.6.5 Siemens Healthineers Recent Developments/Updates
6.7 BD
6.7.1 BD Company Information
6.7.2 BD Description and Business Overview
6.7.3 BD Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 BD Lab Automation in Proteomics Product Portfolio
6.7.5 BD Recent Developments/Updates
6.8 Waters
6.8.1 Waters Company Information
6.8.2 Waters Description and Business Overview
6.8.3 Waters Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Waters Lab Automation in Proteomics Product Portfolio
6.8.5 Waters Recent Developments/Updates
6.9 Hudson Robotics
6.9.1 Hudson Robotics Company Information
6.9.2 Hudson Robotics Description and Business Overview
6.9.3 Hudson Robotics Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hudson Robotics Lab Automation in Proteomics Product Portfolio
6.9.5 Hudson Robotics Recent Developments/Updates
6.10 Synchron
6.10.1 Synchron Company Information
6.10.2 Synchron Description and Business Overview
6.10.3 Synchron Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Synchron Lab Automation in Proteomics Product Portfolio
6.10.5 Synchron Recent Developments/Updates
6.11 Formulatrix
6.11.1 Formulatrix Company Information
6.11.2 Formulatrix Description and Business Overview
6.11.3 Formulatrix Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Formulatrix Lab Automation in Proteomics Product Portfolio
6.11.5 Formulatrix Recent Developments/Updates
6.12 Integra
6.12.1 Integra Company Information
6.12.2 Integra Description and Business Overview
6.12.3 Integra Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Integra Lab Automation in Proteomics Product Portfolio
6.12.5 Integra Recent Developments/Updates
6.13 BRAND
6.13.1 BRAND Company Information
6.13.2 BRAND Description and Business Overview
6.13.3 BRAND Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 BRAND Lab Automation in Proteomics Product Portfolio
6.13.5 BRAND Recent Developments/Updates
6.14 Bio-Rad
6.14.1 Bio-Rad Company Information
6.14.2 Bio-Rad Description and Business Overview
6.14.3 Bio-Rad Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Bio-Rad Lab Automation in Proteomics Product Portfolio
6.14.5 Bio-Rad Recent Developments/Updates
6.15 Shimadzu
6.15.1 Shimadzu Company Information
6.15.2 Shimadzu Description and Business Overview
6.15.3 Shimadzu Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Shimadzu Lab Automation in Proteomics Product Portfolio
6.15.5 Shimadzu Recent Developments/Updates
6.16 Bruker
6.16.1 Bruker Company Information
6.16.2 Bruker Description and Business Overview
6.16.3 Bruker Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.16.4 Bruker Lab Automation in Proteomics Product Portfolio
6.16.5 Bruker Recent Developments/Updates
6.17 Tecan
6.17.1 Tecan Company Information
6.17.2 Tecan Description and Business Overview
6.17.3 Tecan Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.17.4 Tecan Lab Automation in Proteomics Product Portfolio
6.17.5 Tecan Recent Developments/Updates
6.18 Eppendorf
6.18.1 Eppendorf Company Information
6.18.2 Eppendorf Description and Business Overview
6.18.3 Eppendorf Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.18.4 Eppendorf Lab Automation in Proteomics Product Portfolio
6.18.5 Eppendorf Recent Developments/Updates
6.19 Analytic Jena
6.19.1 Analytic Jena Company Information
6.19.2 Analytic Jena Description and Business Overview
6.19.3 Analytic Jena Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.19.4 Analytic Jena Lab Automation in Proteomics Product Portfolio
6.19.5 Analytic Jena Recent Developments/Updates
6.20 SPT Labtech
6.20.1 SPT Labtech Company Information
6.20.2 SPT Labtech Description and Business Overview
6.20.3 SPT Labtech Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.20.4 SPT Labtech Lab Automation in Proteomics Product Portfolio
6.20.5 SPT Labtech Recent Developments/Updates
6.21 Hamilton Company
6.21.1 Hamilton Company Company Information
6.21.2 Hamilton Company Description and Business Overview
6.21.3 Hamilton Company Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.21.4 Hamilton Company Lab Automation in Proteomics Product Portfolio
6.21.5 Hamilton Company Recent Developments/Updates
6.22 Aurora Biomed
6.22.1 Aurora Biomed Company Information
6.22.2 Aurora Biomed Description and Business Overview
6.22.3 Aurora Biomed Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.22.4 Aurora Biomed Lab Automation in Proteomics Product Portfolio
6.22.5 Aurora Biomed Recent Developments/Updates
6.23 Dynex Technologies
6.23.1 Dynex Technologies Company Information
6.23.2 Dynex Technologies Description and Business Overview
6.23.3 Dynex Technologies Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.23.4 Dynex Technologies Lab Automation in Proteomics Product Portfolio
6.23.5 Dynex Technologies Recent Developments/Updates
6.24 Abbott
6.24.1 Abbott Company Information
6.24.2 Abbott Description and Business Overview
6.24.3 Abbott Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.24.4 Abbott Lab Automation in Proteomics Product Portfolio
6.24.5 Abbott Recent Developments/Updates
6.25 Luminex Corporation
6.25.1 Luminex Corporation Company Information
6.25.2 Luminex Corporation Description and Business Overview
6.25.3 Luminex Corporation Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.25.4 Luminex Corporation Lab Automation in Proteomics Product Portfolio
6.25.5 Luminex Corporation Recent Developments/Updates
6.26 Shanghai Vanetterlab
6.26.1 Shanghai Vanetterlab Company Information
6.26.2 Shanghai Vanetterlab Description and Business Overview
6.26.3 Shanghai Vanetterlab Lab Automation in Proteomics Sales, Revenue, and Gross Margin (2021–2026)
6.26.4 Shanghai Vanetterlab Lab Automation in Proteomics Product Portfolio
6.26.5 Shanghai Vanetterlab Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lab Automation in Proteomics Industry Chain Analysis
7.2 Lab Automation in Proteomics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lab Automation in Proteomics Production Mode & Process Analysis
7.4 Lab Automation in Proteomics Sales and Marketing
7.4.1 Lab Automation in Proteomics Sales Channels
7.4.2 Lab Automation in Proteomics Distributors
7.5 Lab Automation in Proteomics Customer Analysis
8 Lab Automation in Proteomics Market Dynamics
8.1 Lab Automation in Proteomics Industry Trends
8.2 Lab Automation in Proteomics Market Drivers
8.3 Lab Automation in Proteomics Market Challenges
8.4 Lab Automation in Proteomics Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Lab Automation in Proteomics market size was US$ 2950 million in 2025 and is forecast to reach a readjusted size of US$ 4513 million by 2032 with a CAGR of 6.4% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 121
USD 4250.00
(Single User License)
The global market for Lab Automation in Proteomics was estimated to be worth US$ 2950 million in 2025 and is projected to reach US$ 4513 million, growing at a CAGR of 6.4% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 175
USD 3950.00
(Single User License)
The global Lab Automation in Proteomics market size was US$ 2791 million in 2024 and is forecast to a readjusted size of US$ 4269 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 125
USD 4250.00
(Single User License)
The global Lab Automation in Proteomics market is projected to grow from US$ 2791 million in 2024 to US$ 4269 million by 2031, at a CAGR of 6.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 211
USD 4900.00
(Single User License)
The global market for Lab Automation in Proteomics was estimated to be worth US$ 2791 million in 2024 and is forecast to a readjusted size of US$ 4269 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 185
USD 3950.00
(Single User License)
The global market for Lab Automation in Proteomics was valued at US$ 2791 million in the year 2024 and is projected to reach a revised size of US$ 4269 million by 2031, growing at a CAGR of 6.4% during the forecast period.
Published Date: 2025-02-07
Pages: 120
USD 2900.00
(Single User License)
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
Published Date: 2024-01-18
Pages: 170
USD 3950.00
(Single User License)
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
Published Date: 2024-01-03
Pages: 107
USD 2900.00
(Single User License)
The global Lab Automation in Proteomics market size was US$ 2950 million in 2025 and is forecast to reach a readjusted size of US$ 4513 million by 2032 with a CAGR of 6.4% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 121
The global market for Lab Automation in Proteomics was estimated to be worth US$ 2950 million in 2025 and is projected to reach US$ 4513 million, growing at a CAGR of 6.4% from 2026 to 2032.
Published: 2026-01-05
Pages: 175
The global Lab Automation in Proteomics market size was US$ 2791 million in 2024 and is forecast to a readjusted size of US$ 4269 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 125
The global Lab Automation in Proteomics market is projected to grow from US$ 2791 million in 2024 to US$ 4269 million by 2031, at a CAGR of 6.4% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 211
The global market for Lab Automation in Proteomics was estimated to be worth US$ 2791 million in 2024 and is forecast to a readjusted size of US$ 4269 million by 2031 with a CAGR of 6.4% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 185
The global market for Lab Automation in Proteomics was valued at US$ 2791 million in the year 2024 and is projected to reach a revised size of US$ 4269 million by 2031, growing at a CAGR of 6.4% during the forecast period.
Published: 2025-02-07
Pages: 120
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
Published: 2024-01-18
Pages: 170
Lab automation is the use of instrumentation to perform laboratory processes, requiring minimal human input. Automation can be used anywhere from a single step of an experimental process, all the way through to the entire workflow. The product range available is now vast, making use of robotics, computers, and software.Automating laboratory tasks improves the overall efficiency of experimental processes by speeding up tasks, cutting waste, using lower quantities of reagents, and allowing for higher throughput of experiments. Combined, this higher efficiency leads to lower running costs of the laboratory. Using automated systems in the lab saves researchers from performing time-consuming and repetitive tasks, freeing them up to carry out more specialized processes. Automation also aims to increase data reliability and accuracy, as error and variability can occur at all stages of the experimental process. Furthermore, automated technology can improve laboratory safety by using automated systems to handle, and correctly store, harmful substances. Consequently, laboratory personnel is more protected from the exposure of these harmful reagents and processes. Proteomics generally refers to the large-scale experimental analysis of proteins and proteomes, advanced laboratory automation equipment has promoted the development of proteomics.
Published: 2024-01-03
Pages: 107
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now